Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 12/08/22
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE AttacksGlobeNewsWire • 12/08/22
Pharvaris Presents Data Supporting HAE Drug Development Strategy at the 2022 HAEi Global Leadership WorkshopGlobeNewsWire • 10/07/22
Pharvaris Announces the Promotion of Annick Deschoolmeester to Chief Human Resources OfficerGlobeNewsWire • 09/30/22
Pharvaris Highlights Data Supporting Clinical Development Program for Hereditary Angioedema at the 2022 Bradykinin SymposiumGlobeNewsWire • 09/16/22
Pharvaris Reports Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 09/12/22
Why Pharvaris Stock Crashed — And Why At Least One Analyst Isn't WorriedInvestors Business Daily • 08/22/22
Pharvaris to Participate in H.C. Wainwright 1st Annual Hereditary Angioedema (HAE) ConferenceGlobeNewsWire • 07/14/22
Pharvaris to Host Virtual Expert Perspectives on HAE: Unmet Needs and Therapeutic Options Webinar on July 13GlobeNewsWire • 07/06/22
Pharvaris Supports HAE Community by Participating in Company-wide Activities Challenge for May 16th hae day :-)GlobeNewsWire • 05/16/22
Pharvaris Reports First Quarter 2022 Financial Results and Provides Business HighlightsGlobeNewsWire • 05/11/22
Pharvaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business HighlightsGlobeNewsWire • 03/29/22
Pharvaris Announces Preclinical Pharmacological Data for Small Molecule PHA121 Published in International ImmunopharmacologyGlobeNewsWire • 03/22/22
Pharvaris to Participate in 11th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/09/22
Pharvaris Reports Third Quarter 2021 Financial Results and Provides Business HighlightsGlobeNewsWire • 11/10/21
Pharvaris Reports Second Quarter 2021 Financial Results and Provides Business HighlightsGlobeNewsWire • 07/30/21
Pharvaris Presents Clinical Data on Oral PHA121 Supporting the Prophylactic Treatment of Hereditary Angioedema at the EAACI Annual Congress 2021GlobeNewsWire • 07/09/21